Interim results from MyCLIMB, a natural history study of pediatric MYBPC3-associated hypertrophic cardiomyopathy

Back

ESC2025 Premium Access

Interim results from MyCLIMB, a natural history study of pediatric MYBPC3-associated hypertrophic cardiomyopathy

Session: Paediatric cardiomyopathy

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor G. Sarquella Brugada (Barcelona, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Georgia Sarquella Brugada

Hospital Sant Joan de Deu, Barcelona (Spain)

2 presentations

3 followers

6 more presentations in this session

Independent predictors of dismal and favourable outcome in adult and paediatric myocarditis: data from the multicentric Italian Rare Biopsy-proven Myocarditis Registry

Speaker: Doctor A. Giordani (Padova, IT)

Analysis of risk factors and construction of predictive model for adverse outcomes of fulminant myocarditis in children

Speaker: Professor B. Han (Jinan, CN)

Clinical characteristics of genetic and gene-elusive arrhythmogenic cardiomyopathy phenotypes in children.

Speaker: Doctor S. Moscatelli (London, GB)

The yield of clinical screening in childhood relatives of individuals with gene-elusive hypertrophic cardiomyopathy

Speaker: Doctor G. Norrish (London, GB) Professor J. Kaski (London, GB)

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy

Speaker: Doctor K. Hirono (Toyama, JP)

Access the full session

Paediatric cardiomyopathy

Speakers: Doctor G. Sarquella Brugada, Doctor A. Giordani, Professor B. Han, Doctor S. Moscatelli, Doctor G. Norrish...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources